Pyxis Oncology is trading 5.6% down at $2.71 today on apparent profit-taking following a recent rally, as no fresh company-specific news or filings have been released to explain the move.
- The decline follows a sharp multi-day run-up earlier in the week, suggesting a technical pullback after recent strength.
- The move comes amid a mixed broader market and an otherwise strong biotech tape, pointing toward normal volatility rather than a new fundamental development.